Statement following the European Medicines Agency review of the COVID-19 vaccine AstraZeneca

Mar 18, 2021

European Commission Statement Brussels, 18 Mar 2021 Following the European Medicines Agency's safety committee's review of the COVID-19 vaccine AstraZeneca at its extraordinary meeting of 18 March 2021, Stella Kyriakides, Commissioner for Health and Food Safety, made the following statement:


Other news